Preventing heart disease through community dialogue
Part of Heart & circulation clinical trials.
This study uses group conversations to help adults without a history of heart disease learn about preventing it by managing cholesterol levels. It focuses on people who have not taken statin medications before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are between 40 and 69 years old
- Have never been diagnosed with coronary heart disease
- Have never taken statin medication for cholesterol
- Have a primary care doctor or regular healthcare provider
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new, personalized ways to prevent heart disease in people with metabolic syndrome. It aims to see if custom approaches can lower your risk of heart attacks and strokes.
This trial tests whether a tailored prevention plan can improve outcomes and help with costs for people at high risk of coronary heart disease. You may join if you’ve had recent heart events or scans show significant blockage, and if you can follow the visit and app requirements.
This trial uses a polygenic risk score to see if knowing your genetic risk for coronary artery disease can help prevent a first heart attack. If you have an intermediate 10-year risk and no prior heart events, you may be eligible.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This trial looks at an individualized prevention approach for people who are at higher risk of heart and blood vessel problems. It aims to help lower future cardiovascular risk before heart disease develops.
This study looks at whether sharing a genetic risk score for heart disease can help people make heart-healthy changes. If you're not on cholesterol medication, you may be able to join.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.